BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31836132)

  • 1. Risk Factors Associated With Invasive Fungal Infections in Kidney Transplant Patients.
    Leitheiser S; Harner A; Waller JL; Turrentine J; Baer S; Kheda M; Nahman NS; Colombo RE
    Am J Med Sci; 2020 Feb; 359(2):108-116. PubMed ID: 31836132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
    Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
    Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts.
    Ajmal S; Mahmood M; Abu Saleh O; Larson J; Sohail MR
    Infection; 2018 Aug; 46(4):555-558. PubMed ID: 29627936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study.
    Hosseini-Moghaddam SM; Ouédraogo A; Naylor KL; Bota SE; Husain S; Nash DM; Paterson JM
    Transpl Infect Dis; 2020 Apr; 22(2):e13250. PubMed ID: 31981389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
    Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
    Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infection in ANCA-associated vasculitis: Between the Devil and Deep blue sea. Case series and review of the literature.
    Baliga S; Yadav S; Sagdeo P; Balakrishnan C
    Clin Rheumatol; 2024 Feb; 43(2):785-797. PubMed ID: 37798405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.
    Zaoutis TE; Webber S; Naftel DC; Chrisant MA; Kaufman B; Pearce FB; Spicer R; Dipchand AI;
    Pediatr Transplant; 2011 Aug; 15(5):465-9. PubMed ID: 21108712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoalbuminemia is a risk factor for invasive fungal infections and poor outcomes in infected kidney transplant recipients.
    Santos A; Jorgenson MR; Osman F; Srivastava A; Misch EA; Garg N; Aziz F; Swanson KJ; Mohamed M; Djamali A; Mandelbrot D; Parajuli S
    Clin Transplant; 2023 Oct; 37(10):e15052. PubMed ID: 37329297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis.
    Phoompoung P; Villalobos APC; Jain S; Foroutan F; Orchanian-Cheff A; Husain S
    J Heart Lung Transplant; 2022 Feb; 41(2):255-262. PubMed ID: 34872817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary.
    Szabo BG; Lakatos B; Bobek I; Szabo E; Szlavik J; Vályi-Nagy I
    J Mycol Med; 2021 Dec; 31(4):101198. PubMed ID: 34428666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.